Alexander E. Kel - Search Results

Year	Number of Results
2002	2
2003	2
2004	2
2005	1
2006	1
2007	2
2008	2
2009	1
2010	3
2013	1
2015	1
2016	2
2017	2
2018	2
2019	1
2022	0

1

Search for Master Regulators in Walking Cancer Pathways.

Kel AE. Kel AE. Methods Mol Biol. 2017;1613:161-191. doi: 10.1007/978-1-4939-7027-8_8. Methods Mol Biol. 2017. PMID: 28849562

2

Molecular mechanistic associations of human diseases.

Stegmaier P, Krull M, Voss N, Kel AE, Wingender E. Stegmaier P, et al. Among authors: kel ae. BMC Syst Biol. 2010 Sep 6;4:124. doi: 10.1186/1752-0509-4-124. BMC Syst Biol. 2010. PMID: 20815942 Free PMC article.

3

Novel sphingolipid derivatives promote keratinocyte differentiation.

Paragh G, Schling P, Ugocsai P, Kel AE, Liebisch G, Heimerl S, Moehle C, Schiemann Y, Wegmann M, Farwick M, Wikonkál NM, Mandl J, Langmann T, Schmitz G. Paragh G, et al. Among authors: kel ae. Exp Dermatol. 2008 Dec;17(12):1004-16. doi: 10.1111/j.1600-0625.2008.00736.x. Exp Dermatol. 2008. PMID: 18631249

4

Mycoplasma hyorhinis reduces sensitivity of human lung carcinoma cells to Nutlin-3 and promotes their malignant phenotype.

Boyarskikh UA, Shadrina AS, Smetanina MA, Tsepilov YA, Oscorbin IP, Kozlov VV, Kel AE, Filipenko ML. Boyarskikh UA, et al. Among authors: kel ae. J Cancer Res Clin Oncol. 2018 Jul;144(7):1289-1300. doi: 10.1007/s00432-018-2658-9. Epub 2018 May 8. J Cancer Res Clin Oncol. 2018. PMID: 29737431

5

DNA methylation and gene expression profiling reveal MFAP5 as a regulatory driver of extracellular matrix remodeling in varicose vein disease.

Smetanina MA, Kel AE, Sevost'ianova KS, Maiborodin IV, Shevela AI, Zolotukhin IA, Stegmaier P, Filipenko ML. Smetanina MA, et al. Among authors: kel ae. Epigenomics. 2018 Aug;10(8):1103-1119. doi: 10.2217/epi-2018-0001. Epub 2018 Aug 2. Epigenomics. 2018. PMID: 30070582

6

FeatureScan: revealing property-dependent similarity of nucleotide sequences.

Deyneko IV, Bredohl B, Wesely D, Kalybaeva YM, Kel AE, Blöcker H, Kauer G. Deyneko IV, et al. Among authors: kel ae. Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W591-5. doi: 10.1093/nar/gkl337. Nucleic Acids Res. 2006. PMID: 16845077 Free PMC article.

7

"Upstream Analysis": An Integrated Promoter-Pathway Analysis Approach to Causal Interpretation of Microarray Data.

Koschmann J, Bhar A, Stegmaier P, Kel AE, Wingender E. Koschmann J, et al. Among authors: kel ae. Microarrays (Basel). 2015 May 21;4(2):270-86. doi: 10.3390/microarrays4020270. Microarrays (Basel). 2015. PMID: 27600225 Free PMC article.

8

Multi-omics "upstream analysis" of regulatory genomic regions helps identifying targets against methotrexate resistance of colon cancer.

Kel AE, Stegmaier P, Valeev T, Koschmann J, Poroikov V, Kel-Margoulis OV, Wingender E. Kel AE, et al. EuPA Open Proteom. 2016 Sep 9;13:1-13. doi: 10.1016/j.euprot.2016.09.002. eCollection 2016 Dec. EuPA Open Proteom. 2016. PMID: 29900117 Free PMC article.

9

Deep insights into the response of human cervical carcinoma cells to a new cyano enone-bearing triterpenoid soloxolone methyl: a transcriptome analysis.

Markov AV, Kel AE, Salomatina OV, Salakhutdinov NF, Zenkova MA, Logashenko EB. Markov AV, et al. Among authors: kel ae. Oncotarget. 2019 Sep 3;10(51):5267-5297. doi: 10.18632/oncotarget.27085. eCollection 2019 Sep 3. Oncotarget. 2019. PMID: 31523389 Free PMC article.

10

MatrixCatch--a novel tool for the recognition of composite regulatory elements in promoters.

Deyneko IV, Kel AE, Kel-Margoulis OV, Deineko EV, Wingender E, Weiss S. Deyneko IV, et al. Among authors: kel ae. BMC Bioinformatics. 2013 Aug 8;14:241. doi: 10.1186/1471-2105-14-241. BMC Bioinformatics. 2013. PMID: 23924163 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results